The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Article numberS41
Number of pages4
JournalAnnals of Translational Medicine
Volume4
Issue numberSuppl 1
DOIs
Publication statusPublished - 1 Oct 2016

Cite this

@article{db5521b666a44147a1aa0a6db222c998,
title = "The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies",
author = "Wilkinson-Berka, {Jennifer L.} and Devy Deliyanti",
year = "2016",
month = "10",
day = "1",
doi = "10.21037/atm.2016.10.27",
language = "English",
volume = "4",
journal = "Annals of Translational Medicine",
issn = "2305-5847",
number = "Suppl 1",

}

The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies. / Wilkinson-Berka, Jennifer L.; Deliyanti, Devy.

In: Annals of Translational Medicine, Vol. 4, No. Suppl 1, S41, 01.10.2016.

Research output: Contribution to journalComment / DebateOtherpeer-review

TY - JOUR

T1 - The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies

AU - Wilkinson-Berka, Jennifer L.

AU - Deliyanti, Devy

PY - 2016/10/1

Y1 - 2016/10/1

UR - http://www.scopus.com/inward/record.url?scp=85011372903&partnerID=8YFLogxK

U2 - 10.21037/atm.2016.10.27

DO - 10.21037/atm.2016.10.27

M3 - Comment / Debate

VL - 4

JO - Annals of Translational Medicine

JF - Annals of Translational Medicine

SN - 2305-5847

IS - Suppl 1

M1 - S41

ER -